SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
January 30, 2013
Date of report (Date of earliest event reported)
BIOLIFE SOLUTIONS, INC.
(Exact Name of Registrant as Specified in Charter)
3303 Monte Villa Parkway, Bothell, WA 98021
(Address of principal executive offices, including zip code)
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
The Board of Directors (the “Board”) of BioLife Solutions, Inc. (the "Company") appointed Rick Stewart to serve as a director effective January 30, 2013. The Board made a qualitative assessment of Mr. Stewart’s level of knowledge and experience based on a number of factors, including his experience leading various technology companies. The Board appointed Mr. Stewart to serve as a member of the Audit Committee of its Board of Directors. Mr. Stewart will receive the standard compensation for nonemployee directors.
On February 4, 2013, the Company issued a press release entitled “BioLife Solutions Appoints Rick Stewart To Board of Directors.” The press release is attached hereto as Exhibit 99.1. The information contained in the press release attached hereto is being furnished and shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of that Section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.